These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32521844)

  • 1. Long non-coding RNA PCAT29 regulates the growth, migration and invasion of human triple-negative breast cancer cells.
    Lu C; Li HL; Zhang X; Zhao J; Zheng WH
    J BUON; 2020; 25(2):621-626. PubMed ID: 32521844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA snaR Regulates Proliferation, Migration and Invasion of Triple-negative Breast Cancer Cells.
    Lee J; Jung JH; Chae YS; Park HY; Kim WW; Lee SJ; Jeong JH; Kang SH
    Anticancer Res; 2016 Dec; 36(12):6289-6295. PubMed ID: 27919948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.
    Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L
    J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
    Yan J; Wang R; Wu Z
    J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of long chain non-coding RNA CTBP1-AS in regulation of invasion and migration of breast cancer cells.
    Cui HB; Geng CZ
    J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):773-785. PubMed ID: 31165609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling.
    Liu L; Yu D; Shi H; Li J; Meng L
    Pharmazie; 2017 Oct; 72(10):599-603. PubMed ID: 29441885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.
    Sun E; Liu X; Lu C; Liu K
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.
    Wang J; Xi C; Yang X; Lu X; Yu K; Zhang Y; Gao R
    Cancer Biother Radiopharm; 2019 Dec; 34(10):671-675. PubMed ID: 31621381
    [No Abstract]   [Full Text] [Related]  

  • 10. Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells.
    Hu XL; Wang J; He W; Zhao P; Wu WQ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3074-3084. PubMed ID: 29863253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
    Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
    J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].
    Xin H; Jiang D; Lü Z; Sun S; Kong J; Li F
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2474-7. PubMed ID: 26711213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis.
    Barton M; Santucci-Pereira J; Vaccaro OG; Nguyen T; Su Y; Russo J
    BMC Cancer; 2019 Oct; 19(1):994. PubMed ID: 31646972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA.
    Yang X; Zhao L; Pei J; Wang Z; Zhang J; Wang B
    Breast Cancer Res Treat; 2020 Aug; 183(1):71-82. PubMed ID: 32601971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death.
    Beltrán-Anaya FO; Romero-Córdoba S; Rebollar-Vega R; Arrieta O; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Alfaro-Riuz L; Jiménez-Morales S; Cedro-Tanda A; Ríos-Romero M; Reyes-Grajeda JP; Tagliabue E; Iorio MV; Hidalgo-Miranda A
    Mol Oncol; 2019 Apr; 13(4):909-927. PubMed ID: 30648789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of long non-coding RNA UCA1 inhibits proliferation and invasion and induces apoptosis in human lung cancer cells.
    Jun T; Zheng FS; Ren KM; Zhang HY; Zhao JG; Zhao JZ
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7274-7281. PubMed ID: 30468471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.
    Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
    Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.